title: Aureobasidium pullulans fungal keratitis following LASEK.
abstract: OBJECTIVE
  To describe a patient who developed Aureobasidium pullulans keratitis following refractive laser epithelial keratomileusis (LASEK).
  
  
  METHODS
  A 52-year-old woman was referred to a tertiary care center 1 month after LASEK for treatment of a corneal ulcer that was unresponsive to conventional therapy. Mycology culture and fungal stain identified Aureobasidium as the infectious organism.
  
  
  RESULTS
  The infection responded well to treatment with topical natamycin and systemic itraconazole.
  
  
  CONCLUSIONS
  Treatment with topical natamycin and systemic itraconazole is effective against Aureobasidium pullulans keratitis.
authors.affiliation: Focal Point Vision Correction, San Antonio, Texas 78229, USA. maverick@focalpointvision.com
authors.forename: Kenneth J
authors.initials: KJ
authors.lastname: Maverick
authors.forename: Michael S
authors.initials: MS
authors.lastname: Conners
mesh_terms: D000287:Administration, Topical; D000935:Antifungal Agents / Q000627:therapeutic use; D001203:Ascomycota / Q000302:isolation & purification*; D003320:Corneal Ulcer / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D004359:Drug Therapy, Combination; D015821:Eye Infections, Fungal / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D005260:Female; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use; D049008:Keratectomy, Subepithelial, Laser-Assisted; D008875:Middle Aged; D009181:Mycoses / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D010866:Natamycin / Q000627:therapeutic use; D011183:Postoperative Complications
chemical_list: D000935:Antifungal Agents; D017964:Itraconazole; D010866:Natamycin